RadNet (RadNet) LT-Debt-to-Total-Asset : 0.53 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is RadNet LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. RadNet's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.53.

RadNet's long-term debt to total assets ratio declined from Dec. 2022 (0.59) to Dec. 2023 (0.53). It may suggest that RadNet is progressively becoming less dependent on debt to grow their business.

RadNet LT-Debt-to-Total-Asset Historical Data

The historical data trend for RadNet's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RadNet LT-Debt-to-Total-Asset Chart

RadNet Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.65

0.60

0.64

0.59

0.53

RadNet Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.59	0.61	0.55	0.54	0.53

RadNet LT-Debt-to-Total-Asset Calculation

RadNet's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1417.165	/	2690.473
	=	0.53

RadNet's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	1417.165	/	2690.473
	=	0.53

RadNet (NAS:RDNT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

RadNet LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of RadNet's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

RadNet (RadNet) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RadNet Inc (NAS:RDNT) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

SHC NEOG GH TWST NEO MYGN VCYT LAB OPK FLGT TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

PQIA:Germany

Address

1510 Cotner Avenue, Los Angeles, CA, USA, 90025

Website

http://www.radnet.com

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

Executives

Michael N Murdock	officer: Executive Vice President	3600 JP MORGAN CHASE TOWER, 2200 ROSS AVENUE, DALLAS TX 752012776
Christine Nayoma Gordon	director	3081 PANAMA AVE., CARMICHAEL CA 95608
Gregory Sorensen	director, officer: EVP Chief Science Officer	C/O DFB HEALTHCARE ACQUISITIONS CORP, 780 THIRD AVENUE, NEW YORK NY 10017
Norman R Hames	director, officer: Vice President
Stephen M Forthuber	officer: Executive Vice President	3600 JP MORGAN CHASE TOWER, 2200 ROSS AVENUE, DALLAS TX 75201-2776
Ruth Louisa Villigerwilson	director, officer: Senior Vice President	3700 WALNUT AVENUE, LONG BEACH CA 90801
David L Swartz	director	1510 COTNER AVENUE, LOS ANGELES CA 90025
Gregory E. Spurlock	director	4116 E. NORTHRIDGE CIRCLE, MESA AZ 85215-9807
John V Crues	director	1510 COTNER AVE, LOS ANGELES CA 90025
Lawrence L Levitt	director	2934 1/2 BEVERLY GLEN CIRCLE #325, LOS ANGELES CA 90077
Ranjan Jayanathan	officer: Chief Information Officer	13388 HUNT RIDGE ROAD, ELLICOTT CITY MD 21042
Laura Pastre Jacobs	director	10154 BRIDLEVALE DRIVE, LOS ANGELES CA 90064
Karen B. Kaplan Survivor's Trust	other: Indirect owner	10776 WILSHIRE BLVD/, LOS ANGELES CA 90024-6447
David Jeffrey Katz	officer: EVP and General Counsel	1510 COTNER AVE, LOS ANGELES CA 90025
Sherman Michael L Md	director